Neurocrine to Buy Soleno for $2.9 Billion Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion in a move intended to expand its endocrinology and rare-disease portfolio. Post navigation Previous Previous post: Shoei Helmet Owners, Cardo’s Got Two New Comms Systems Specifically For YouNext Next post: Neurocrine to Buy Soleno for $2.9 Billion Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related News Battle Born Batteries: Where Are They Made & How Reliable Are They? 0 Why You Should Buy Electronics From Costco (Instead Of Amazon) 0
